Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
NEUROSURGERY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
direct	O
admission	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Stereotactic	O
Brain	O
Biopsy	O
___	O
History	O
of	O
Present	O
Illness:	O
___	O
is	O
a	O
___	O
right-handed	O
orthodox	O
Jewish	O
man,	O
with	O
history	O
of	O
hypertension,	O
hypercholesterolemia,	O
CHF,	O
and	O
COPD,	O
and	O
CABGx	O
3	O
vessels,	O
who	O
is	O
seen	O
in	O
consultation	O
as	O
requested	O
by	O
Dr.	O
___	O
from	O
the	O
Orthopedics	O
Service	O
for	O
evaluation	O
of	O
an	O
enhancing	O
mass	O
in	O
the	O
right	O
superior	O
temporal	O
region	O
of	O
the	O
brain.	O
His	O
neurological	O
problem	O
began	O
after	O
his	O
partial	O
vertebrectomy	O
and	O
spinal	O
fusion	O
at	O
L5	O
and	O
S1	O
on	O
___.	O
The	O
radiating	O
sciatic	O
pain	O
from	O
his	O
low	O
back	O
to	O
the	O
left	O
posterior	O
thigh	O
and	O
left	O
posterior	O
leg	O
resolved	O
after	O
surgery.	O
But	O
while	O
in	O
rehabilitation,	O
he	O
experienced	O
confusion	O
and	O
disorientation,	O
accompanied	O
by	O
spastic	O
arms.	O
A	O
head	O
CT	O
performed	O
outside	O
showed	O
a	O
right	O
temporal	O
brain	O
mass.	O
He	O
was	O
placed	O
on	O
dexamethasone	O
on	O
___.	O
Today,	O
he	O
is	O
scheduled	O
to	O
wean	O
dexamethasone	O
from	O
6	O
mg	O
twice	O
daily	O
to	O
4	O
mg	O
twice	O
daily.	O
He	O
also	O
had	O
a	O
gadolinium-enhanced	O
head	O
MRI	O
at	O
___	O
on	O
___.	O
It	O
showed	O
heterogenous	O
gadolinium	O
enhancement	O
with	O
adjacent	O
cerebral	O
edema.	O
He	O
is	O
here	O
today	O
for	O
a	O
consultation	O
about	O
potential	O
diagnoses	O
and	O
management.	O
Of	O
note,	O
he	O
is	O
currently	O
in	O
hospice	O
at	O
home.	O
His	O
daughter,	O
his	O
wife,	O
and	O
a	O
friend	O
are	O
in	O
the	O
clinic	O
with	O
him.	O
Past	O
Medical	O
History:	O
-	O
Hypertension	O
-	O
GERD	O
-	O
Hyperlipidemia	O
-	O
Benign	O
prostatic	O
hypertrophy	O
-	O
COPD	O
-	O
FEV1	O
38%,	O
FEV1/FVC	O
62%	O
predicted,	O
not	O
on	O
home	O
O2	O
-	O
Sleep-disordered	O
breathing	O
on	O
CPAP/bipap	O
at	O
home	O
-	O
CAD	O
S/p	O
CABG	O
x	O
3,	O
___	O
-	O
Sciatica,	O
spinal	O
stenosis	O
-	O
Hx	O
Spinal	O
fusion	O
surgery	O
-	O
S/p	O
inguinal	O
hernia	O
repair	O
-	O
Hiatal	O
hernia	O
-	O
Diastolic	O
dysfunction/LVH,	O
no	O
echo	O
in	O
system	O
-	O
paralyzed	O
right	O
hemidiaphragm	O
Social	O
History:	O
___	O
Family	O
History:	O
His	O
family	O
history	O
is	O
notable	O
for	O
his	O
mother	O
who	O
died	O
of	O
a	O
stroke.	O
His	O
father	O
had	O
peptic	O
ulcer	O
disease	O
and	O
dementia	O
before	O
he	O
died.	O
There	O
is	O
no	O
history	O
of	O
lung	O
disease	O
or	O
lung	O
cancer	O
in	O
the	O
family.	O
Physical	O
Exam:	O
ON	O
ADMISSION	O
NAD	O
A&Ox3	O
PERRL	O
EOMI	O
face	O
symmetrical	O
No	O
pronator	O
drift	O
tongue	O
midline	O
fluent	O
speech	O
wound	O
clean/dry/intact	O
Motor	O
___	O
in	O
bilateral	O
UE's	O
LLE:	O
___	O
motor	O
throughout	O
RLE	O
___	O
except	O
for	O
tib	O
ant	O
(___),	O
___	O
(___),	O
gastrocnemius	O
(___)	O
EXAM	O
AT	O
DISCHARGE:	O
GEN:	O
elderly	O
man,	O
lying	O
in	O
bed	O
NAD	O
HEENT:	O
OP	O
clear	O
CV:	O
RRR	O
PULM:	O
CTAB	O
ABD:	O
soft,	O
NT,	O
ND	O
EXT:	O
trace	O
edema	O
at	O
ankles	O
bilaterally	O
NEURO:	O
MS	O
-	O
AAOx3	O
CN	O
-	O
EOMI,	O
PERRL	O
4->3,	O
face	O
symmetrical,	O
facial	O
sensation	O
intact,	O
tongue	O
midline	O
MOTOR	O
-	O
___	O
in	O
bilateral	O
UE's	O
and	O
LLE.	O
However,	O
in	O
RLE,	O
___	O
in	O
TA,	O
___	O
in	O
___	O
and	O
___	O
in	O
gastrocnemius,	O
otherwise	O
strength	O
intact	O
SENSORY	O
-	O
intact	O
to	O
LT	O
GAIT	O
-	O
deferred,	O
as	O
pt	O
bedbound	O
currently	O
Pertinent	O
Results:	O
CT	O
STEREOTACTIC	O
BIOPSY	O
FINDINGS:	O
Comparison	O
is	O
made	O
with	O
the	O
___	O
enhanced	O
cranial	O
MR,	O
dated	O
___,	O
uploaded	O
to	O
PACS.	O
There	O
is	O
a	O
hypodense	O
mass	O
centered	O
in	O
the	O
right	O
temporal	O
lobe	O
with	O
peripheral	O
enhancement,	O
measuring	O
approximately	O
41	O
x	O
41	O
mm.	O
Two	O
satellite	O
lesions	O
are	O
seen	O
in	O
the	O
anterior-inferior	O
right	O
temporal	O
lobe.	O
There	O
is	O
surrounding	O
vasogenic	O
edema	O
extending	O
superiorly.	O
There	O
is	O
5	O
mm	O
leftward	O
shift	O
of	O
normally	O
midline	O
structures.	O
There	O
is	O
no	O
hydrocephalus.	O
There	O
is	O
no	O
CT	O
evidence	O
for	O
acute	O
intracranial	O
hemorrhage	O
although	O
evaluation	O
is	O
slightly	O
limited	O
in	O
the	O
setting	O
of	O
administration	O
of	O
intravenous	O
contrast.	O
Limited	O
evaluation	O
of	O
intracranial	O
vessels	O
demonstrates	O
no	O
acute	O
abnormality.	O
The	O
visualized	O
portions	O
of	O
the	O
paranasal	O
sinuses	O
and	O
mastoid	O
air	O
cells	O
appear	O
well	O
aerated.	O
IMPRESSION:	O
4	O
cm	O
peripherally	O
enhancing	O
mass	O
centered	O
in	O
the	O
right	O
temporal	O
lobe	O
with	O
extensive	O
surrounding	O
vasogenic	O
edema	O
and	O
5	O
mm	O
leftward	O
shift	O
of	O
normally-	O
midline	O
structures,	O
improved	O
from	O
the	O
OSH	O
study.	O
CT	O
HEAD	O
POST-OP	O
___:	O
IMPRESSION:	O
Right	O
temporoparietal	O
mass,	O
as	O
seen	O
previously,	O
with	O
expected	O
post-operative	O
changes,	O
s/p	O
biopsy	O
via	O
right	O
parietal	O
burr	O
hole.	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
was	O
directly	O
admitted	O
to	O
the	O
neurosurgical	O
service	O
at	O
___	O
on	O
___	O
for	O
a	O
steretactic	O
brain	O
mass	O
biopsy.	O
The	O
procedure	O
went	O
well	O
but	O
afterwards	O
he	O
experienced	O
a	O
brief	O
episode	O
of	O
hypotension.	O
The	O
medicine	O
service	O
was	O
consulted	O
and	O
it	O
was	O
determined	O
that	O
this	O
episode	O
was	O
likely	O
due	O
to	O
the	O
anesthesia.	O
He	O
was	O
transferred	O
from	O
the	O
PACU	O
to	O
the	O
floor	O
and	O
he	O
remained	O
hemodynamically	O
stable,	O
without	O
any	O
other	O
episodes	O
of	O
hypotension.	O
On	O
postoperative	O
day	O
1	O
he	O
remained	O
stable	O
and	O
was	O
deemed	O
ready	O
for	O
discharge	O
to	O
home	O
with	O
instructions	O
for	O
the	O
appropriate	O
follow-up	O
care.	O
On	O
the	O
day	O
of	O
discharge	O
he	O
c/o	O
nausea,	O
then	O
burning	O
midline	O
chest	O
pain	O
with	O
an	O
associated	O
feeling	O
of	O
fullness.	O
He	O
was	O
burping	O
frequently	O
on	O
exam	O
and	O
reported	O
that	O
he	O
has	O
had	O
this	O
sensation	O
previously	O
and	O
his	O
wife	O
"gives	O
me	O
drops"	O
and	O
it	O
goes	O
away.	O
We	O
obtained	O
an	O
EKG	O
which	O
was	O
unchanged	O
from	O
prior	O
and	O
3	O
set	O
of	O
cardiac	O
enzymes	O
which	O
were	O
negative.	O
He	O
was	O
able	O
to	O
be	O
sent	O
home	O
the	O
next	O
day.	O
Medications	O
on	O
Admission:	O
ALBUTEROL	O
SULFATE	O
[PROAIR	O
HFA]	O
-	O
90	O
mcg	O
HFA	O
Aerosol	O
Inhaler	O
-	O
___	O
puffs(s)	O
inhaled	O
every	O
___	O
hours	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing	O
DEXAMETHASONE	O
-	O
(Prescribed	O
by	O
Other	O
Provider;	O
Dose	O
adjustment	O
-	O
no	O
new	O
Rx)	O
-	O
4	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
FLUTICASONE	O
-	O
50	O
mcg	O
Spray,	O
Suspension	O
-	O
___	O
sprays	O
each	O
nostril	O
daily	O
HYDROCHLOROTHIAZIDE	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
25	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
LISINOPRIL	O
-	O
(Prescribed	O
by	O
Other	O
Provider;	O
Dose	O
adjustment	O
-	O
no	O
new	O
Rx)	O
-	O
10	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
LORAZEPAM	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
1	O
mg	O
Tablet	O
-	O
2	O
Tablet(s)	O
by	O
mouth	O
hlaf	O
a	O
pill	O
twice	O
daily	O
and	O
1	O
mg	O
at	O
bedtime	O
METOPROLOL	O
TARTRATE	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
50	O
mg	O
Tablet	O
-	O
0.5	O
(One	O
half)	O
Tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
OMEPRAZOLE	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
-	O
1	O
Capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
PRAVASTATIN	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
40	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
PRAZOSIN	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
1	O
mg	O
Capsule	O
-	O
1	O
Capsule(s)	O
by	O
mouth	O
at	O
bedtime	O
SILVER	O
SULFADIAZINE	O
[SILVADENE]	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
1	O
%	O
Cream	O
-	O
apply	O
as	O
directed	O
with	O
each	O
dressing	O
change	O
SPIRONOLACTONE	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
25	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
TIOTROPIUM	O
BROMIDE	O
[SPIRIVA	O
WITH	O
HANDIHALER]	O
-	O
18	O
mcg	O
Capsule,	O
w/Inhalation	O
Device	O
-	O
1	O
capsule(s)	O
inhaled	O
once	O
a	O
day	O
Medications	O
-	O
OTC	O
ASCORBIC	O
ACID	O
[VITAMIN	O
C]	O
-	O
(OTC)	O
-	O
1,000	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
ASPIRIN	O
-	O
(Prescribed	O
by	O
Other	O
Provider)	O
-	O
81	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
CHOLECALCIFEROL	O
(VITAMIN	O
D3)	O
[VITAMIN	O
D3]	O
-	O
(OTC)	O
-	O
1,000	O
unit	O
Tablet,	O
Chewable	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
IRON-VITAMIN	O
B	O
COMPLEX	O
WITH	O
C	O
[SUPER	O
B	O
COMPLEX]	O
-	O
(OTC)	O
-	O
27	O
mg-300	O
mg	O
Tablet	O
-	O
1	O
Tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
MULTIVITAMIN	O
-	O
(OTC)	O
-	O
Capsule	O
-	O
1	O
Capsule(s)	O
by	O
mouth	O
once	O
a	O
day	O
VIT	O
C-VIT	O
E-COPPER-ZNOX-LUTEIN	O
[PRESERVISION]	O
-	O
(OTC)	O
-	O
226	O
mg-200	O
unit-5	O
mg-0.8	O
mg-34.8	O
mg	O
Capsule	O
-	O
1	O
Capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Discharge	O
Medications:	O
1.	O
albuterol	O
sulfate	O
90	O
mcg/actuation	O
HFA	O
Aerosol	O
Inhaler	O
Sig:	O
Two	O
(2)	O
Puff	O
Inhalation	O
Q4H	O
(every	O
4	O
hours)	O
as	O
needed	O
for	O
SOB.	O
2.	O
fluticasone	O
50	O
mcg/actuation	O
Spray,	O
Suspension	O
Sig:	O
___	O
Sprays	O
Nasal	O
DAILY	O
(Daily).	O
3.	O
hydrochlorothiazide	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
4.	O
lisinopril	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
Ativan	O
1	O
mg	O
Tablet	O
Sig:	O
___	O
Tablet	O
PO	O
three	O
times	O
a	O
day:	O
0.5mg	O
BID	O
and	O
1mg	O
QHS.	O
6.	O
metoprolol	O
tartrate	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
7.	O
omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
twice	O
a	O
day.	O
8.	O
pravastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
9.	O
prazosin	O
1	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
at	O
bedtime.	O
10.	O
tiotropium	O
bromide	O
18	O
mcg	O
Capsule,	O
w/Inhalation	O
Device	O
Sig:	O
One	O
(1)	O
Cap	O
Inhalation	O
DAILY	O
(Daily).	O
11.	O
furosemide	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
12.	O
furosemide	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
13.	O
cholecalciferol	O
(vitamin	O
D3)	O
1,000	O
unit	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
14.	O
multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
15.	O
oxycodone	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q4H	O
(every	O
4	O
hours)	O
as	O
needed	O
for	O
pain.	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
16.	O
dexamethasone	O
4	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
every	O
eight	O
(8)	O
hours.	O
Disp:*90	O
Tablet(s)*	O
Refills:*1*	O
17.	O
atorvastatin	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
18.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
twice	O
a	O
day.	O
Disp:*60	O
Capsule(s)*	O
Refills:*2*	O
19.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	O
Disp:*60	O
Tablet(s)*	O
Refills:*0*	O
20.	O
Silvadene	O
1	O
%	O
Cream	O
Sig:	O
One	O
(1)	O
application	O
Topical	O
once	O
a	O
day	O
as	O
needed	O
for	O
wound	O
healing.	O
21.	O
Vitamin	O
C	O
1,000	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
22.	O
PreserVision	O
226-200-5	O
mg-unit-mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
twice	O
a	O
day.	O
23.	O
Super	O
B-50	O
Complex	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
day.	O
24.	O
spironolactone	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
25.	O
Keppra	O
500	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day.	O
Disp:*60	O
Tablet(s)*	O
Refills:*3*	O
26.	O
Home	O
Nasal	O
Cannula	O
Oxygen	O
Patient	O
to	O
have	O
nasal	O
cannula	O
oxygen	O
for	O
8	O
hours	O
at	O
night	O
at	O
2L	O
of	O
flow.	O
His	O
resting	O
O2	O
sat	O
on	O
room	O
air	O
is	O
97%.	O
He	O
is	O
bedbound,	O
so	O
unable	O
to	O
test	O
his	O
exertional	O
O2	O
saturation.	O
Diagnosis:	O
Coronary	O
Artery	O
Disease	O
and	O
COPD	O
27.	O
Zofran	O
8	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
every	O
eight	O
(8)	O
hours	O
as	O
needed	O
for	O
nausea.	O
Disp:*90	O
Tablet(s)*	O
Refills:*0*	O
28.	O
aspirin	O
81	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
once	O
a	O
day.	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
enhancing	O
mass	O
in	O
the	O
right	O
superior	O
temporal	O
region	O
of	O
the	O
brain	O
Discharge	O
Condition:	O
Stable	O
Activity	O
Status:	O
Out	O
of	O
Bed	O
with	O
assistance	O
to	O
chair	O
or	O
wheelchair.	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
came	O
into	O
the	O
hospital	O
for	O
a	O
brain	O
biopsy	O
after	O
having	O
been	O
seen	O
in	O
brain	O
tumor	O
clinic.	O
You	O
had	O
the	O
biopsy	O
done	O
on	O
___	O
and	O
the	O
pathology	O
is	O
still	O
pending.	O
We	O
made	O
the	O
following	O
changes	O
to	O
your	O
medications:	O
1)	O
We	O
STARTED	O
you	O
on	O
OXYCODONE	O
5mg	O
every	O
4	O
hours	O
as	O
needed	O
for	O
pain.	O
2)	O
We	O
INCREASED	O
your	O
DEXAMETHASONE	O
to	O
4mg	O
three	O
times	O
a	O
day.	O
Your	O
doctor	O
___	O
tell	O
you	O
when	O
to	O
decrease	O
this	O
medication.	O
3)	O
We	O
STARTED	O
you	O
on	O
DOCUSATE	O
100mg	O
twice	O
a	O
day.	O
Please	O
take	O
this	O
medication	O
while	O
you	O
are	O
on	O
the	O
above	O
oxycodone.	O
You	O
may	O
continue	O
to	O
take	O
this	O
afterwards	O
for	O
prevention	O
of	O
constipation.	O
4)	O
We	O
STARTED	O
you	O
on	O
SENNA	O
8.6mg	O
twice	O
a	O
day	O
as	O
needed	O
for	O
constipation.	O
5)	O
We	O
HELD	O
your	O
ASPIRIN	O
until	O
___	O
when	O
you	O
may	O
restart	O
this	O
medication.	O
6)	O
We	O
STARTED	O
you	O
on	O
KEPPRA	O
500mg	O
twice	O
a	O
day	O
to	O
help	O
prevent	O
seizures.	O
7)	O
We	O
STARTED	O
you	O
on	O
ZOFRAN	O
8mg	O
three	O
times	O
a	O
day	O
as	O
needed	O
for	O
nausea.	O
Please	O
continue	O
to	O
take	O
your	O
other	O
medications	O
as	O
previously	O
prescribed.	O
We	O
were	O
unable	O
to	O
fully	O
confirm	O
your	O
list	O
of	O
home	O
medications.	O
Therefore,	O
please	O
continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
as	O
you	O
were	O
taking	O
them	O
previously	O
except	O
for	O
the	O
above	O
changes	O
that	O
we	O
made.	O
If	O
you	O
experience	O
the	O
below	O
listed	O
Danger	O
Signs,	O
please	O
contact	O
your	O
doctor	O
or	O
go	O
to	O
the	O
nearest	O
Emergency	O
Room.	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
on	O
this	O
hospitalization.	O
General	O
Instructions/Information	O
Have	O
a	O
friend/family	O
member	O
check	O
your	O
incision	O
daily	O
for	O
signs	O
of	O
infection.	O
Take	O
your	O
pain	O
medicine	O
as	O
prescribed.	O
Exercise	O
should	O
be	O
limited	O
to	O
walking;	O
no	O
lifting,	O
straining,	O
or	O
excessive	O
bending.	O
Your	O
wound	O
closure	O
uses	O
dissolvable	O
sutures,	O
so	O
you	O
must	O
keep	O
that	O
area	O
dry	O
for	O
10	O
days.	O
You	O
may	O
shower	O
before	O
this	O
time	O
using	O
a	O
shower	O
cap	O
to	O
cover	O
your	O
head.	O
Increase	O
your	O
intake	O
of	O
fluids	O
and	O
fiber,	O
as	O
narcotic	O
pain	O
medicine	O
can	O
cause	O
constipation.	O
We	O
generally	O
recommend	O
taking	O
an	O
over	O
the	O
counter	O
stool	O
softener,	O
such	O
as	O
Docusate	O
(Colace)	O
while	O
taking	O
narcotic	O
pain	O
medication.	O
Unless	O
directed	O
by	O
your	O
doctor,	O
do	O
not	O
take	O
any	O
anti-inflammatory	O
medicines	O
such	O
as	O
Motrin,	O
Aspirin,	O
Advil,	O
and	O
Ibuprofen	O
etc.	O
You	O
can	O
start	O
taking	O
your	O
aspirin	O
again	O
on	O
___.	O
You	O
are	O
being	O
sent	O
home	O
on	O
steroid	O
medication,	O
so	O
make	O
sure	O
you	O
are	O
taking	O
a	O
medication	O
to	O
protect	O
your	O
stomach	O
(Prilosec,	O
Protonix,	O
or	O
Pepcid),	O
as	O
these	O
medications	O
can	O
cause	O
stomach	O
irritation.	O
Make	O
sure	O
to	O
take	O
your	O
steroid	O
medication	O
with	O
meals,	O
or	O
a	O
glass	O
of	O
milk.	O
Clearance	O
to	O
drive	O
and	O
return	O
to	O
work	O
will	O
be	O
addressed	O
at	O
your	O
post-operative	O
office	O
visit.	O
Make	O
sure	O
to	O
continue	O
to	O
use	O
your	O
incentive	O
spirometer	O
while	O
at	O
home.	O
CALL	O
YOUR	O
SURGEON	O
IMMEDIATELY	O
IF	O
YOU	O
EXPERIENCE	O
ANY	O
OF	O
THE	O
FOLLOWING	O
New	O
onset	O
of	O
tremors	O
or	O
seizures.	O
Any	O
confusion	O
or	O
change	O
in	O
mental	O
status.	O
Any	O
numbness,	O
tingling,	O
weakness	O
in	O
your	O
extremities.	O
Pain	O
or	O
headache	O
that	O
is	O
continually	O
increasing,	O
or	O
not	O
relieved	O
by	O
pain	O
medication.	O
Any	O
signs	O
of	O
infection	O
at	O
the	O
wound	O
site:	O
increasing	O
redness,	O
increased	O
swelling,	O
increased	O
tenderness,	O
or	O
drainage.	O
Fever	O
greater	O
than	O
or	O
equal	O
to	O
101°	O
F.	O
Follow-Up	O
Appointment	O
Instructions	O
You	O
have	O
an	O
appointment	O
in	O
the	O
Brain	O
Tumor	O
Clinic	O
on	O
___	O
at	O
10:30am.	O
The	O
Brain	O
Tumor	O
Clinic	O
is	O
located	O
on	O
the	O
East	O
Campus	O
of	O
___,	O
in	O
the	O
___	O
Building,	O
___	O
floor.	O
Their	O
phone	O
number	O
is	O
___.	O
Please	O
call	O
if	O
you	O
need	O
to	O
change	O
your	O
appointment,	O
or	O
require	O
additional	O
directions.	O
Followup	O
Instructions:	O
___	O

